AstraZenecaMEX:AZNN +1.25%87 FCF Margin % is 11.91% as of Mar. 2026, which is 27% above its 10-year median of 9.39. GuruFocus rates MEX:AZNN with a GF Score™ of 87/100 and a GF Value™ of MXN1,523.85. The stock has 5 warning signs investors should review. Among 958 Drug Manufacturers companies, AstraZeneca ranks better than 76.51% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. AstraZeneca's Free Cash Flow for the
three
months ended in Mar. 2026 was MXN32,838 Mil. AstraZeneca's Revenue for the
three
months ended in Mar. 2026 was MXN275,684 Mil. Therefore, AstraZeneca's FCF Margin % for the quarter that ended in Mar. 2026 was 11.91%.
The historical rank and industry rank for AstraZeneca's FCF Margin % or its related term are showing as below:
MEX:AZNN'
s FCF Margin % Range Over the Past 10 Years
Min: 2.09 Med: 9.39 Max: 16.32
Current: 12.84
During the past 13 years, the highest FCF Margin % of AstraZeneca was 16.32%. The lowest was 2.09%. And the median was 9.39%.
MEX:AZNN's FCF Margin % is ranked better than 76.51% of 958
companies
in the Drug Manufacturers industry
Industry Median: 2.445
vs MEX:AZNN: 12.84
AstraZeneca FCF Margin % Related Terms
AstraZeneca FCF Margin % Historical Data
* Premium members only.
The historical data trend for AstraZeneca's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:AZNN vs LLY, JNJ, ABBV: FCF Margin % Comparison
For the Drug Manufacturers - General subindustry, AstraZeneca's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AstraZeneca FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, AstraZeneca's FCF Margin % distribution charts can be found below:
* The bar in red indicates where AstraZeneca's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AstraZeneca (MEX:AZNN) has a FCF Margin % of 11.91% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on AstraZeneca and its competitors. This is 27% above median its historical median of 9.39. Over the past decade, AstraZeneca's FCF Margin % has ranged from 2.09 to 16.32. According to the industry distribution chart, AstraZeneca ranks #225 out of 958 companies in the Drug Manufacturers industry, placing it in the top 23.5%.
Is AstraZeneca's FCF Margin % too high?
AstraZeneca's current FCF Margin % of 11.91% is 27% above median its 10-year median of 9.39. Over the past 10 years, this metric has ranged from a low of 2.09 to a high of 16.32. The Drug Manufacturers industry median FCF Margin % is 2.45. AstraZeneca's value of 11.91% is 387.1% above this industry median. Based on the distribution chart, AstraZeneca ranks #225 out of 958 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, AstraZeneca has a GF Score™ of 87/100, reflecting its overall financial health beyond just this single metric.
How does AstraZeneca's FCF Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, AstraZeneca ranks #225 out of 958 companies for FCF Margin %. This places AstraZeneca in the top 24% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.45. AstraZeneca's value of 11.91% is 387.1% above this benchmark. Historically, AstraZeneca's own FCF Margin % has ranged from 2.09 to 16.32 over the past decade. While the company's 10-year median is 9.39 vs. the industry median of 2.45, AstraZeneca has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AstraZeneca's current FCF Margin % of 11.91% is 387.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on AstraZeneca and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AstraZeneca's current FCF Margin % is 11.91%, which is 27% above median its own 10-year median of 9.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AstraZeneca stock overvalued right now?
AstraZeneca (MEX:AZNN) has a current FCF Margin % of 11.91%. The stock's GF Value™ is MXN1,523.85, compared to a current price of MXN1,628.00 — trading 6.8% above its estimated fair value. The current FCF Margin % is 11.91%, which is 27% above median its 10-year median of 9.39 and 387.1% above the Drug Manufacturers industry median of 2.45. AstraZeneca's overall GF Score™ is 87/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For AstraZeneca (MEX:AZNN), the current FCF Margin % is 11.91% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AstraZeneca (MEX:AZNN) Overvalued in 2026?
Based on GuruFocus' analysis, AstraZeneca stock appears to be overvalued.
The current stock price of MXN1,628.00 is trading 6.8% above its estimated GF Value™ of MXN1,523.85.
Key valuation signals for MEX:AZNN:
FCF Margin %: 11.91% (27% above median its 10-year median of 9.39)
GF Value™: MXN1,523.85 vs. price of MXN1,628.00 (6.8% above fair value)
Industry Position: 387.1% above the Drug Manufacturers median (#225 of 958)
No single metric tells the full story. See the MEX:AZNN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
87GF Score
Get the complete analysis for MEX:AZNN
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:AZNN has been successfully added to your 
